17. Pediatric Bipolar Disorder: The Promise of Psychopharmacotherapy

  1. Hagop S. Akiskal2 and
  2. Mauricio Tohen3
  1. Tiffany Thomas and
  2. Robert L. Findling

Published Online: 13 APR 2011

DOI: 10.1002/9780470975114.ch17

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

How to Cite

Thomas, T. and Findling, R. L. (2011) Pediatric Bipolar Disorder: The Promise of Psychopharmacotherapy, in Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition (eds H. S. Akiskal and M. Tohen), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9780470975114.ch17

Editor Information

  1. 2

    International Mood Center, University of California at San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0603, USA

  2. 3

    Department of Psychiatry, Division of Mood and Anxiety Disorders, University of Texas Health Science Centre at San Antonio, 7730 Floyd Curl Drive, San Antonio, TX 78229, USA

Author Information

  1. Division of Child and Adolescent Psychiatry, University Hospitals Case Medical Center, 10524 Euclid Avenue, Cleveland, OH 44106, USA

Publication History

  1. Published Online: 13 APR 2011
  2. Published Print: 15 APR 2011

ISBN Information

Print ISBN: 9780470747216

Online ISBN: 9780470975114

SEARCH

Keywords:

  • pediatric bipolar disorder;
  • pharmacotherapy;
  • lithium;
  • mood stabilizers;
  • anticonvulsants;
  • atypical antipsychotics;
  • children;
  • adolescents;
  • acute treatment;
  • maintenance treatment

Summary

Pediatric bipolar disorder is a serious and chronic illness that can have debilitating effects on the lives of children and adolescents suffering from this disorder. Pharmacological therapy is a mainstay in the management of pediatric bipolar disorder. Until not too long ago, there was very little research of methodological rigor regarding the medication treatment of these vulnerable youngsters. However, over the past few years, clinical trials in the pharmacotherapy of pediatric bipolar disorder have been conducted and new data are emerging. These studies include the use of lithium, anticonvulsants/mood stabilizers, and atypical antipsychotics for the acute and long-term treatment of pediatric bipolar disorder. Despite these new advances, further placebo-controlled trials investigating the efficacy and safety (both acute and long-term) of pharmacologic interventions are still needed in this population.